Indications
For the treatment and prevention of flea (Ctenocephalides felis) infestations in dogs where one or more of the following indications are required concurrently: prevention of heartworm disease (L3, L4 Dirofilaria immitis); prevention of angiostrongylosis by reducing the level of infection with immature adult (L5) Angiostrongylus vasorum; treatment of gastrointestinal nematode infections caused by hookworm (L4, immature adult, L5) and adult Ancylostoma caninum), roundworms (immature adult L5, and adult Toxocara canis and adult Toxascaris leonina) and whipworm (adult Trichuris vulpis).
Composition
- Active substance
- spinosad, milbemycin oxime
- International name (INN)
- spinosad;milbemycin oxime
Official product information
The European public assessment report holds the summary of product characteristics and the package leaflet in every EU language.
Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.
At a glance
- Medicine
- Trifexis
- Active substance
- spinosad, milbemycin oxime
- Group
- Veterinary medicines